Literature DB >> 7647595

Potential mechanisms of improvement after various treatments for hypertrophic obstructive cardiomyopathy.

R D Leachman1.   

Abstract

In sum, systolic dysfunction of the ventricle associated with left ventricular outlet obstruction and often with mitral valve regurgitation may be improved by myotomy, myomectomy, mitral valve replacement, and perhaps by the creation of left bundle branch block via DDD right ventricular pacing. Diastolic dysfunction of the ventricle may be improved by prolonging the diastolic filling period, shortening the isovolumic relaxation period with calcium channel blocking drugs, or perhaps by altering the atrioventricular activation time with a DDD pacemaker. The symptoms and complications of associated arrhythmias may be improved by medication, particularly with beta-blockers, which tend to stabilize the atrial rhythm and perhaps the ventricular rhythms. In treating patients with demonstrated ventricular arrhythmias, other antiarrhythmic agents may be helpful. (Table II summarizes the abnormalities, causes, and treatments of hypertrophic obstructive cardiomyopathy.) Epicardial coronary atherosclerosis is not rare in these patients, and arteriographic confirmation may lead to improvement by surgical bypass treatment. Since stroke volume is nearly fixed, cardiac output depends very much on heart rate. For this reason, each patient needs to receive the appropriate dosage of medications to achieve the optimal heart rate for his or her own physiologic state.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7647595      PMCID: PMC325231     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN: 0730-2347


  39 in total

1.  Asymmetrical hypertrophy of the heart in young adults.

Authors:  D TEARE
Journal:  Br Heart J       Date:  1958-01

2.  Hypertrophic subaortic stenosis. Clinical and hemodynamic effects of long-term propranolol therapy.

Authors:  R E Stenson; M D Flamm; D C Harrison; E W Hancock
Journal:  Am J Cardiol       Date:  1973-06       Impact factor: 2.778

3.  Mitral valve movement in hypertrophic obstructive cardiomyopathy.

Authors:  R B Pridie; C Oakley
Journal:  Br Heart J       Date:  1969-05

4.  Arrhythmia in hypertrophic cardiomyopathy. II: Comparison of amiodarone and verapamil in treatment.

Authors:  W J McKenna; L Harris; G Perez; D M Krikler; C Oakley; J F Goodwin
Journal:  Br Heart J       Date:  1981-08

5.  Left bundle branch block and mechanical events of the cardiac cycle.

Authors:  H N Hultgren; E Craige; J Fujii; T Nakamura; J Bilisoly
Journal:  Am J Cardiol       Date:  1983-10-01       Impact factor: 2.778

6.  Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features.

Authors:  W McKenna; J Deanfield; A Faruqui; D England; C Oakley; J Goodwin
Journal:  Am J Cardiol       Date:  1981-03       Impact factor: 2.778

7.  Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.

Authors:  B J Maron; D D Savage; J K Wolfson; S E Epstein
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

8.  Functional abnormalities in isolated left bundle branch block. The effect of interventricular asynchrony.

Authors:  C L Grines; T M Bashore; H Boudoulas; S Olson; P Shafer; C F Wooley
Journal:  Circulation       Date:  1989-04       Impact factor: 29.690

9.  Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy.

Authors:  X Jeanrenaud; J J Goy; L Kappenberger
Journal:  Lancet       Date:  1992-05-30       Impact factor: 79.321

10.  "Malignant" hypertrophic cardiomyopathy: identification of a subgroup of families with unusually frequent premature death.

Authors:  B J Maron; L C Lipson; W C Roberts; D D Savage; S E Epstein
Journal:  Am J Cardiol       Date:  1978-06       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.